MPP6 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.114400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.622400E-01
Normal-vs-Stage2
3.793200E-01
Normal-vs-Stage3
1.372640E-01
Normal-vs-Stage4
2.192400E-01
Stage1-vs-Stage2
3.330600E-01
Stage1-vs-Stage3
2.716800E-01
Stage1-vs-Stage4
3.309800E-01
Stage2-vs-Stage3
6.869800E-01
Stage2-vs-Stage4
7.578800E-01
Stage3-vs-Stage4
9.097800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.158000E-01
Normal-vs-AfricanAmerican
7.315200E-01
Normal-vs-Asian
3.091800E-02
Caucasian-vs-AfricanAmerican
6.976000E-02
Caucasian-vs-Asian
3.981700E-02
AfricanAmerican-vs-Asian
9.069600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.420400E-01
Normal-vs-Female
2.857000E-01
Male-vs-Female
1.136840E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.209800E-01
Normal-vs-Age(41-60Yrs)
7.315600E-01
Normal-vs-Age(61-80Yrs)
2.186000E-01
Normal-vs-Age(81-100Yrs)
4.056800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.933400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.827200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.160200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.170500E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.942400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.210400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.841230E-01
Normal-vs-Daily Drinker
4.099900E-02
Normal-vs-Weekly Drinker
6.001400E-01
Normal-vs-Occasional Drinker
5.861800E-01
Normal-vs-Social Drinker
8.192400E-01
Non Drinker-vs-Daily Drinker
3.211400E-01
Non Drinker-vs-Weekly Drinker
5.532000E-01
Non Drinker-vs-Occasional Drinker
5.173200E-01
Non Drinker-vs-Social Drinker
3.976400E-01
Daily Drinker-vs-Weekly Drinker
2.585600E-01
Daily Drinker-vs-Occasional Drinker
2.095400E-01
Daily Drinker-vs-Social Drinker
2.055400E-01
Weekly Drinker-vs-Occasional Drinker
9.884200E-01
Weekly Drinker-vs-Social Drinker
7.556200E-01
Occasional Drinker-vs-Social Drinker
7.252000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.900400E-01
Normal-vs-Grade 2
6.339000E-01
Normal-vs-Grade 3
6.791400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.011400E-01
Grade 1-vs-Grade 3
8.382400E-01
Grade 1-vs-Grade 4
6.900400E-01
Grade 2-vs-Grade 3
1.811990E-01
Grade 2-vs-Grade 4
6.339000E-01
Grade 3-vs-Grade 4
6.791400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.236000E-01
Normal-vs-NonDiabetic
2.886400E-01
Diabetic-vs-NonDiabetic
5.802200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.278500E-03
Normal-vs-NoPancreatitis
4.010800E-01
Pancreatitis-vs-NoPancreatitis
3.922200E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.267800E-01
Normal-vs-N1
4.043600E-01
N0-vs-N1
8.639800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.991400E-01
Normal-vs-TP53-NonMutant
9.285200E-01
TP53-Mutant-vs-TP53-NonMutant
3.037800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
